Matrix Capital Management Company, LP - 31 Mar 2025 SCHEDULE 13G Report for Maze Therapeutics, Inc. Common Stock, $0.001 par value per share (MAZE)

Filing Manager
Matrix Capital Management Company, LP
Reporting Manager
Matrix Capital Management Company, LP
Security
Maze Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
MAZE
Shares outstanding
43.6M shares
Disclosed Ownership
2.49M shares
Ownership
5.7%
Form type
SCHEDULE 13G
Date filed
14 May 2025, 16:10
Date of event
31 Mar 2025
Next filing
13 Nov 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Matrix Capital Management Company, LP 5.7% 2.49M 0 2.49M /s/ David E. Goel David E. Goel, Managing General Partner
David E. Goel 5.7% 2.49M 0 2.49M /s/ David E. Goel David E. Goel, individually